180 related articles for article (PubMed ID: 36831296)
1. Expression of Basement Membrane Molecules by Wharton Jelly Stem Cells (WJSC) in Full-Term Human Umbilical Cords, Cell Cultures and Microtissues.
Sánchez-Porras D; Durand-Herrera D; Carmona R; Blanco-Elices C; Garzón I; Pozzobon M; San Martín S; Alaminos M; García-García ÓD; Chato-Astrain J; Carriel V
Cells; 2023 Feb; 12(4):. PubMed ID: 36831296
[TBL] [Abstract][Full Text] [Related]
2. Wharton's jelly-derived mesenchymal cells as a new source for the generation of microtissues for tissue engineering applications.
Durand-Herrera D; Campos F; Jaimes-Parra BD; Sánchez-López JD; Fernández-Valadés R; Alaminos M; Campos A; Carriel V
Histochem Cell Biol; 2018 Oct; 150(4):379-393. PubMed ID: 29931444
[TBL] [Abstract][Full Text] [Related]
3. Freezing of Fresh Wharton's Jelly From Human Umbilical Cords Yields High Post-Thaw Mesenchymal Stem Cell Numbers for Cell-Based Therapies.
Fong CY; Subramanian A; Biswas A; Bongso A
J Cell Biochem; 2016 Apr; 117(4):815-27. PubMed ID: 26365815
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of Wharton's jelly-derived multipotent mesenchymal stromal cells obtained from bovine umbilical cord and maintained in a defined serum-free three-dimensional system.
Cardoso TC; Ferrari HF; Garcia AF; Novais JB; Silva-Frade C; Ferrarezi MC; Andrade AL; Gameiro R
BMC Biotechnol; 2012 May; 12():18. PubMed ID: 22559872
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of cell cycle and WNT pathway-related genes accounts for differences in the growth and differentiation potential of Wharton's jelly and bone marrow-derived mesenchymal stem cells.
Batsali AK; Pontikoglou C; Koutroulakis D; Pavlaki KI; Damianaki A; Mavroudi I; Alpantaki K; Kouvidi E; Kontakis G; Papadaki HA
Stem Cell Res Ther; 2017 Apr; 8(1):102. PubMed ID: 28446235
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of the Impact of Pregnancy-Associated Factors on the Quality of Wharton's Jelly-Derived Stem Cells Using SOX2 Gene Expression as a Marker.
Gil-Kulik P; Świstowska M; Krzyżanowski A; Petniak A; Kwaśniewska A; Płachno BJ; Galkowski D; Bogucka-Kocka A; Kocki J
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35886978
[TBL] [Abstract][Full Text] [Related]
7. Derivation efficiency, cell proliferation, freeze-thaw survival, stem-cell properties and differentiation of human Wharton's jelly stem cells.
Fong CY; Subramanian A; Biswas A; Gauthaman K; Srikanth P; Hande MP; Bongso A
Reprod Biomed Online; 2010 Sep; 21(3):391-401. PubMed ID: 20638335
[TBL] [Abstract][Full Text] [Related]
8. Increased Expression of
Gil-Kulik P; Świstowska M; Kondracka A; Chomik P; Krzyżanowski A; Kwaśniewska A; Rahnama M; Kocki J
Oxid Med Cell Longev; 2020; 2020():9084730. PubMed ID: 32322338
[TBL] [Abstract][Full Text] [Related]
9. Derivation of Mesenchymal Stromal Cells from Ovine Umbilical Cord Wharton's Jelly.
Carreras-Sánchez I; López-Fernández A; Rojas-Márquez R; Vélez R; Aguirre M; Vives J
Curr Protoc; 2021 Jan; 1(1):e18. PubMed ID: 33484488
[TBL] [Abstract][Full Text] [Related]
10. Enhanced neuro-therapeutic potential of Wharton's Jelly-derived mesenchymal stem cells in comparison with bone marrow mesenchymal stem cells culture.
Drela K; Lech W; Figiel-Dabrowska A; Zychowicz M; Mikula M; Sarnowska A; Domanska-Janik K
Cytotherapy; 2016 Apr; 18(4):497-509. PubMed ID: 26971678
[TBL] [Abstract][Full Text] [Related]
11. The effect of vascular complications of diabetes mellitus on human umbilical cord tissue and the number of Wharton Jelly's mesenchymal stem cells.
Karaca C; Bostancıeri N; Ovayolu A; Kahraman DT
Mol Biol Rep; 2020 Dec; 47(12):9313-9323. PubMed ID: 33179142
[TBL] [Abstract][Full Text] [Related]
12. Human Wharton's jelly mesenchymal stem cells: properties, isolation and clinical applications.
Borys-Wójcik S; Brązert M; Jankowski M; Ożegowska K; Chermuła B; Piotrowska-Kempisty H; Bukowska D; Antosik P; Pawelczyk L; Nowicki M; Jeseta M; Kempisty B
J Biol Regul Homeost Agents; 2019 Jan-Feb,; 33(1):119-123. PubMed ID: 30729769
[TBL] [Abstract][Full Text] [Related]
13. Immunosuppressive properties of mesenchymal stromal cells derived from amnion, placenta, Wharton's jelly and umbilical cord.
Manochantr S; U-pratya Y; Kheolamai P; Rojphisan S; Chayosumrit M; Tantrawatpan C; Supokawej A; Issaragrisil S
Intern Med J; 2013 Apr; 43(4):430-9. PubMed ID: 23176558
[TBL] [Abstract][Full Text] [Related]
14. Human-derived extracellular matrix from Wharton's jelly: An untapped substrate to build up a standardized and homogeneous coating for vascular engineering.
Dan P; Velot É; Francius G; Menu P; Decot V
Acta Biomater; 2017 Jan; 48():227-237. PubMed ID: 27769940
[TBL] [Abstract][Full Text] [Related]
15. Characteristics of mesenchymal stem cells derived from Wharton's jelly of human umbilical cord and for fabrication of non-scaffold tissue-engineered cartilage.
Liu S; Hou KD; Yuan M; Peng J; Zhang L; Sui X; Zhao B; Xu W; Wang A; Lu S; Guo Q
J Biosci Bioeng; 2014 Feb; 117(2):229-235. PubMed ID: 23899897
[TBL] [Abstract][Full Text] [Related]
16. Comparison of human mesenchymal stem cells isolated by explant culture method from entire umbilical cord and Wharton's jelly matrix.
Hendijani F; Sadeghi-Aliabadi H; Haghjooy Javanmard S
Cell Tissue Bank; 2014 Dec; 15(4):555-65. PubMed ID: 24532125
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cells derived from Wharton's jelly: comparative phenotype analysis between tissue and in vitro expansion.
Margossian T; Reppel L; Makdissy N; Stoltz JF; Bensoussan D; Huselstein C
Biomed Mater Eng; 2012; 22(4):243-54. PubMed ID: 22785368
[TBL] [Abstract][Full Text] [Related]
18. Chondrogenic induction of mesenchymal stromal/stem cells from Wharton's jelly embedded in alginate hydrogel and without added growth factor: an alternative stem cell source for cartilage tissue engineering.
Reppel L; Schiavi J; Charif N; Leger L; Yu H; Pinzano A; Henrionnet C; Stoltz JF; Bensoussan D; Huselstein C
Stem Cell Res Ther; 2015 Dec; 6():260. PubMed ID: 26718750
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of human Wharton's jelly mesenchymal stem cells derived from different parts of the same umbilical cord.
Bharti D; Shivakumar SB; Park JK; Ullah I; Subbarao RB; Park JS; Lee SL; Park BW; Rho GJ
Cell Tissue Res; 2018 Apr; 372(1):51-65. PubMed ID: 29204746
[TBL] [Abstract][Full Text] [Related]
20. Improving stemness and functional features of mesenchymal stem cells from Wharton's jelly of a human umbilical cord by mimicking the native, low oxygen stem cell niche.
Obradovic H; Krstic J; Trivanovic D; Mojsilovic S; Okic I; Kukolj T; Ilic V; Jaukovic A; Terzic M; Bugarski D
Placenta; 2019 Jul; 82():25-34. PubMed ID: 31174623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
